innisfree Gentle Retinol Salicylic Acne Serum

Manufacturer
Innisfree Corporation
Effective date
2025-01-08
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 00:56:18

Label at a glance#

Productinnisfree Gentle Retinol Salicylic Acne Serum
Active ingredientSALICYLIC ACID
Label structure10 sections

Indications and uses

For the treatment of acne. Penetrates pores to control blackheads and whiteheads. Helps prevent the development of new acne blemishes.

Dosage and administration

■ Clean the skin thoroughly before applying this product. ■ Cover the entire affected area with a thin layer one to three times daily. ■ If bothersome dryness or peeling occurs, reduce application to once a day or every other day. ■ Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed as directed by a doctor.

Storage and handling

Protect the product in this container from excessive heat and direct sun

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

ACTIVE INGREDIENTS

OTC - ACTIVE INGREDIENT SECTION

Salicylic acid 2%

Purpose

OTC - PURPOSE SECTION

Acne treatment

Uses

INDICATIONS & USAGE SECTION

  • For the treatment of acne.
  • Penetrates pores to control blackheads and whiteheads.
  • Helps prevent the development of new acne blemishes.

Warnings

WARNINGS SECTION

For external use only

OTC - WHEN USING SECTION

When using this product skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication .

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

■ Clean the skin thoroughly before applying this product.
■ Cover the entire affected area with a thin layer one to three times daily.
■ If bothersome dryness or peeling occurs, reduce application to once a day
or every other day.
■ Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed as directed by a doctor.

Other information

STORAGE AND HANDLING SECTION

Protect the product in this container from excessive heat and direct sun

Inactive ingredients

INACTIVE INGREDIENT SECTION

WATER / AQUA / EAU, GLYCERIN, BUTYLENE GLYCOL, NIACINAMIDE, DICAPRYLYL CARBONATE, TROMETHAMINE, BETAINE,
1,2-HEXANEDIOL, HYDROGENATED LECITHIN, AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER, CAPRYLIC/CAPRIC TRIGLYCERIDE, HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE
COPOLYMER, CHOLESTEROL, HELIANTHUS ANNUUS (SUNFLOWER) SEED OIL, ALLANTOIN, LACTOBACILLUS FERMENT LYSATE, GLYCINE SOJA (SOYBEAN) OIL, TOCOPHEROL, TOCOPHERYL ACETATE, SODIUM
METHYL STEAROYL TAURATE, PROPANEDIOL, DAUCUS CAROTA SATIVA (CARROT) ROOT EXTRACT, ETHYLHEXYLGLYCERIN, ADENOSINE, SORBITAN ISOSTEARATE, CAMELLIA SINENSIS SEED EXTRACT, ASIATICOSIDE, MADECASSIC ACID, RETINOL, ASIATIC ACID, PHYTOSPHINGOSINE, STEARYL GLYCYRRHETINATE, HYALURONIC ACID, CERAMIDE NP, BETA-GLUCAN, BETA-CAROTENE

Questions?

POSTMARKETING EXPERIENCE SECTION

support@us.amorepacific.com

Innisfree GENTLE RETINOL SALICYLIC ACNE SERUM

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Innisfree

GENTLE RETINOL SALICYLIC ACNE SERUM
ACNE TREATMENT SERUM

GREEN TEA SOOTHING COMPLEX
ACNE + BLEMISH CARE

30 mL
1.01 Fl. Oz.

acneacne

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
346298salicylic acid 2 % Topical GelPSN1
346298salicylic acid 0.02 MG/MG Topical GelSCD1
346298salicylic acid 2 % Topical GelSY1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
77dc03a4-fbfc-e6a3-fe95-285bbae40d75Product name220250814
d1c9d1af-bddd-448d-86f7-69052b7d5b47Product name120220627
baf7f49c-75b6-496b-a00e-8e766a8e4f03Product name120210127
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408
d676a241-be05-4740-b3ee-1a5f2ed422d2Product name420180615
dd8bd48f-20d6-43c7-b471-3ae872868afaProduct name320180125
ebc62596-fc97-4d03-9483-7ba095d25db7Product name120151210
d41954ff-bc63-4b2c-aba0-9146707659d7Product name220151117
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71220-088-02innisfree Gentle Retinol Salicylic Acne Serum1 in 1 BOXGEL11
71220-088-02innisfree Gentle Retinol Salicylic Acne Serum30 mL in 1 TUBEGEL301

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
71220-088INNISFREE GENTLE RETINOL SALICYLIC ACNE SERUM (SALICYLIC ACID GEL) GEL [INNISFREE CORPORATION]1Current NDC, 2 package rows20250302_2b38b6f2-0de5-581b-e063-6394a90acd55.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 36 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
71220-08871220-088-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 34 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
innisfree Gentle Retinol Salicylic Acne SerumSALICYLIC ACID GELInnisfree Corporation2b38b6f2-0de5-581b-e063-6394a90acd552025-01-08WarningsExact identifier
ndc (package): 71220-088-02
ndc (product): 71220-088
ndc11 (package): 71220008802
spl id: 2b38c5cc-cb91-3168-e063-6294a90a5abc
spl set id: 2b38b6f2-0de5-581b-e063-6394a90acd55

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.